KatherineAJanewayMD

Associate Professor, Pediatrics-Children's Hospital, Harvard Medical School

Dr. Janeway is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
Dana Farber Cancer Institute
44 Binney Street
Boston, MA 02115
Phone+1 617-632-4994

Boston Children’s Hospital/Boston Medical CenterFellowship, Pediatric Hematology/Oncology, 2004 - 2007
Boston Children’s Hospital/Boston Medical CenterResidency, Pediatrics, 2000 - 2004
Harvard Medical SchoolClass of 2000

PubMed

331 citations
Institutional implementation of clinical tumor profiling on an unselected cancer population
Lynette M. Sholl, Khanh T. Do, Priyanka Shivdasani, Ethan Cerami, Adrian M. Dubuc
JCI Insight. 2016-11-17
29 citations
Renal medullary carcinomas depend upon SMARCB1 loss and are sensitive to proteasome inhibition.
Andrew L. Hong, Yuen-Yi Tseng, Jeremiah Wala, Won Jun Kim, Bryan D. Kynnap
Elife. 2019-03-12
40 citations
Integrated genetic and pharmacologic interrogation of rare cancers
Andrew L. Hong, Yuen-Yi Tseng, Glenn S. Cowley, Oliver Jonas, Jaime H. Cheah
Nature Communications. 2016-06-22

Journal Articles

Institutional Implementation of Clinical Tumor Profiling on an Unselected Cancer Population
Khanh Do, Lauren L Ritterhouse, William C Hahn, Geoffrey I Shapiro, Barrett J Rollins, Neal I Lindeman, Alanna Church, Geoffrey R Oxnard, Bruce E Johnson, Frank C Kuo,..., The Journal of Clinical Investigation
Integrated Genetic and Pharmacologic Interrogation of Rare Cancers
Andrew L Hong, Katherine A Janeway, Brian D Crompton, Kimberly Stegmaier, Levi A Garraway, Alanna J Church, Stuart L Schreiber, William C Hahn, Nature

Lectures

Matched Targeted Therapy for Pediatric Patients with Relapsed, Refractory or High-Risk Leukemias: A Report from the LEAP ConsortiumClinically Relevant Abstract
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Refining the Genomic Landscape of Pediatric Cancers
2018 ASCO Annual Meeting - Chicago, Illinois - 06/2/2018

Other

Chemotherapy and radiation therapy in the management of osteosarcoma
Janeway KA, Goorin AM, Maki R
http://www.uptodate.com/contents/chemotherapy-and-radiation-therapy-in-the-management-of-osteosarcom
UpToDate, Wolters Kluwer Health - 2012-12-06

Genomic ‘Fingerprinting’ Yields Better Treatments for Pediatric Solid CancersJune 24th, 2022
Study Shows That Genomic Tumor Profiling of Pediatric Tumors Can Enhance Clinical CareJune 23rd, 2022
A Discussion with Cancer Discovery’s Editors-in-ChiefAugust 5th, 2021
Join now to see all